"10.1371_journal.pone.0020881","plos one","2011-06-08T00:00:00Z","Adrien L√©ger; Caroline Le Guiner; Michael L Nickerson; Kate McGee Im; Nicolas Ferry; Philippe Moullier; Richard O Snyder; Magalie Penaud-Budloo","INSERM UMR649, Nantes, France; G√©n√©thon, Evry, France; National Cancer Institute, National Institutes of Health, Frederick, Maryland, United States of America; INSERM UMR948, Nantes, France; Department of Molecular Genetics and Microbiology, College of Medicine, University of Florida, Gainesville, Florida, United States of America; Center of Excellence for Regenerative Health Biotechnology, University of Florida, Alachua, Florida, United States of America","Conceived and designed the experiments: MPB AL RS PM. Performed the experiments: MPB AL. Analyzed the data: MPB AL MN KMI. Wrote the paper: MPB AL RS. Performed 454 sequencing at the Core Genotyping Facility (National Cancer Institute, Gaithersburg, Maryland): MN KMI. Performed animal experiments: CLG NF.","The authors have read the journals policy and have the following conflicts of interest: RS owns equity in a gene therapy company that is commercializing AAV for gene therapy applications (Applied Genetic Technologies Corporation Alachua, Florida). To the extent that the work in this manuscript increases the value of these commercial holdings, RS has a conflict of interest. None of the authors are employed by a commercial company. G√©n√©thon is a non-profit French research institute funded by Association fran√ßaise contre les Myopathies (AFM). There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all PLoS ONE policies on sharing data and materials.","2011","06","Adrien L√©ger","AL√",8,TRUE,4,2,4,3,TRUE,TRUE,FALSE,0,NA,FALSE
